Keyphrases
Inflammatory Bowel Disease
100%
Glutamate Carboxypeptidase II (GCPII)
91%
Prostate-specific Antigen
86%
Matrix Metalloproteinases
61%
Urokinase-type Plasminogen Activator
61%
Inflammation
40%
Enzymatic Activity
35%
Prodrug
35%
Antitumor Activity
34%
Colon
33%
Tumor
32%
Enzymatic Cofactor
30%
Comparative Toxicity
30%
Comparative Efficacy
30%
Murine Colitis
30%
Loss Function
30%
Anthrax Toxin
30%
DOCK2
30%
Oxidase
30%
Glutathione
30%
Serine Protease
30%
Dimethyl
30%
Anthrax Lethal Toxin
30%
Dipeptidyl peptidase-IV (DPP-IV)
30%
Proteolytic Degradation
30%
6-diazo-5-oxo-l-norleucine
30%
Oral Midazolam
30%
Midazolam Clearance
30%
Prostasin
30%
Colitis
30%
Imaging Biomarkers
30%
PRSS8
30%
Ritonavir
30%
Homeostasis
30%
Tumor Targeting
30%
Prostate
30%
Common Marmoset
30%
Placental Morphogenesis
30%
18F-DCFPyL
30%
Maternal Barriers
30%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
30%
Confounding Variables
30%
Systemic Administration
30%
Membrane-anchored Serine Protease
30%
PET Radiotracers
30%
Callithrix Jacchus
30%
Disease Research
30%
Metabolic Inhibitors
30%
Epidermal Development
30%
Peptide Drugs
30%
Medicine and Dentistry
Inflammatory Bowel Disease
94%
Glutamate Carboxypeptidase II Inhibitor
73%
Glutamate Carboxypeptidase II
70%
Colitis
61%
Anthrax Toxin
61%
Prostate Specific Membrane Antigen
52%
Neoplasm
45%
Colon
43%
Matrix Metalloproteinase
42%
Disease
37%
Urokinase
34%
Glutathione
30%
Midazolam
30%
Macrophage
30%
Collagen Degradation
30%
Fluorine-18
30%
Biological Marker
30%
Systemic Administration
30%
Lethal Gene
30%
Head and Neck Squamous Cell Carcinoma
30%
Mannose Receptor
30%
Ritonavir
30%
Gut
30%
Oxidoreductase
30%
Radioactive Tracer
30%
Positron Emission Tomography
30%
CYP3A
22%
Tumor Cell
20%
Patient with Inflammatory Bowel Disease
20%
Calgranulin
17%
Dextran Sulfate
17%
Upregulation
14%
Gamma Glutamyl Hydrolase
13%
Prostate Cancer
13%
In Vitro
12%
Dextran Sulfate Sodium-Induced Colitis
12%
Low Drug Dose
11%
Drug Interaction
11%
Disease Activity
11%
Imaging Agent
10%
Ex Vivo
10%
Head and Neck Squamous Cell Carcinoma Cell Line
10%
Mucosa
10%
Stromal Cell
10%
Antineoplastic Activity
9%
Angiogenesis
9%
Biopsy
9%
Positron Emission Tomography
8%
Oligomer
8%
Radiation Therapy
8%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
92%
Glutamate Carboxypeptidase II Inhibitor
73%
Glutamate Carboxypeptidase II
70%
Inflammatory Bowel Disease
68%
Colitis
61%
Urokinase
61%
Matrix Metalloproteinase
61%
Dipeptidyl Peptidase IV
61%
Mouse
44%
Serine Proteinase
36%
Prodrug
34%
Proteinase
34%
Disease
31%
Boronic Acid Derivative
30%
Anthrax Toxin
30%
Oxidoreductase
30%
6 Diazo 5 Oxonorleucine
30%
Systemic Administration
30%
Midazolam
30%
Inflammation
30%
Ritonavir
30%
Head and Neck Squamous Cell Carcinoma
30%
Dipeptide
30%
Glutathione
30%
Anthrax
30%
CYP3A
22%
Prostate Specific Membrane Antigen
21%
Dextran Sulfate
17%
Malignant Neoplasm
13%
Prostate Cancer
13%
Gamma Glutamyl Hydrolase
13%
Dipeptidyl Peptidase IV Inhibitor
12%
Dextran Sulfate Sodium-Induced Colitis
12%
CD8 Antigen
10%
Biological Activity
10%
Glucagon Like Peptide 1 [7-36] Amide
10%
Chymotrypsin
10%
Clinical Trial
10%
Dipeptidyl Peptidase
10%
Amino Acid Derivative
10%
Glutamine
10%
Melanoma
8%
Maximum Tolerated Dose
8%
Drug-Drug Interaction
7%
Incretin
6%
Glucagon-Like Peptide-1
6%
Genetically Engineered Mouse Strain
6%
Gastric Inhibitory Polypeptide
6%
Disease Activity
6%
Wild Type Mouse
6%
